(3.80.3.192)
Users online: 2407    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 2
First page : ( 624) Last page : ( 626)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00118.3

An Analysis of Antiasthmatic preparations available in Indian Market

Dr. Elango Anitha1,*, Dr. Punnagai K.2, Dr. Chellathai Darling3, Dr. Elizebeth Arul Amutha4

1Assistant Professor, Department of Pharmacology, Sree Balaji Medical College, Chromepet, Chennai

2Professor, Sree Balaji Medical College, Chromepet, Chennai

3HOD and Professor, Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai-600116

4HOD and Professor, Department of Pharmacology, Sree Balaji Medical College, Chromepet, Chennai

*Corresponding Author E-mail: dr.anishan@gmail.com

Online published on 9 April, 2020.

Abstract

Objective

To analyse various anti-asthmatic preparations available in the Indian market and to study their cost effectiveness and rationality of drug preparations.

Materials and methods

Various formulations which is used for asthma mentioned in Current Index of Medical Specialities (CIMS) (2018) were noted down. Their rationality and irrational combination of drug preparations were recorded as per Drug Controller General of India (DCGI) (2018). Moreover they are classified into number of ingredients present in each preparation, type of dosage forms, different pharmacological groups to which they belong and cost analysis of the anti-asthmatic preparations.

Results

Among 598 preparations which has been analysed, 360 (60%) were fixed dose combinations (FDC). Out of 360 FDC, 250(42%) preparations were of irrational formulations. Preparations were categorised into different pharmacological groups like expectorants (18.73%), antihistamines (17.22%), beta 2 adrenergic agonists (50.17%), mucolytics (20.57%), cromones (1%), methylxanthines (16.38%), corticosteroids (24.08%), antileukotrienes (23.91%), anticholinergics (3.85%).187 preparations were inhalants and 10 of the preparations were nasal formulations. Solid formulations (244) are more when compared to other formulations and liquid oral formulations are costlier.

Conclusion

Many of the drugs which was considered as irrational by DCGI is still available in Indian market and it is widely used by the people. This indicates the poor governance in the pharmaceutical sector. Through proper awareness and education to the pharmacist, physician and patient this problem could be solved. Moreover it also leads to the wasteful expenditure and effectiveness of the drug is also questionable.

Top

Keywords

Anti-asthmatic medicines, cost evaluation, rationality analysis.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
520,709,424 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.